Clinical Trial Update: The Effect of Ferric Carboxymaltose on Hemoglobin and Blood Transfusion in Cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 study assessing whether ferric carboxymaltose improves hemoglobin levels and reduces blood transfusions in patients undergoing cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Anemia | Phase 4 | Status: UNKNOWN